Original Literature | Model OverView |
---|---|
Publication
Title
Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins.
Affiliation
School of Biochemistry and Immunology, Trinity College, Dublin, Ireland.wattert@tcd.ie
Abstract
The Toll/IL-1 receptor (TIR) domain plays a central role in Toll-like receptor(TLR) signalling. All TLRs contain a cytoplasmic TIR domain, which, uponactivation, acts as a scaffold to recruit adaptor proteins. The adaptor proteinsMyD88, Mal, TRIF, TRAM and SARM are also characterized by the presence of a TIRdomain. MyD88, Mal, TRIF and TRAM associate with the TLRs via homophilic TIRdomain interactions whereas SARM utilizes its TIR domain to negatively regulateTRIF. It is well established that the differential recruitment of adaptors toTLRs provides a significant amount of specificity to the TLR-signallingpathways. Despite this, the TIR-TIR interface has not been well defined.However, structural studies have indicated the importance of TIR domain surfacesin mediating specific TIR-TIR interactions. Furthermore, recent findingsregarding the regulation of adaptors provide further insight into the crucialrole of the TIR domain in TLR signalling.
PMID
17667936
|
Entity
Process
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
csml-variable:Double
m207
10
infinite
0
--
csml-variable:Double
m3963
10
infinite
0
--
csml-variable:Double
m3964
10
infinite
0
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
Inflammatory cytokines
--
e100
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m100
0
infinite
0
--
IRF1
--
e101
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m101
0
infinite
0
--
IRF1{active}
--
e102
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m102
0
infinite
0
--
IRF1{active}
--
e103
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m103
0
infinite
0
--
IFN-beta
--
e104
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m104
0
infinite
0
--
Inos
--
e105
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m105
0
infinite
0
--
IL-12p35
--
e106
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m106
0
infinite
0
--
Mal
--
e107
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m107
0
infinite
0
--
TLR4{dimer}:MD-2:LPS:LBP:CD14:Mal
--
e108
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m108
0
infinite
0
--
TLR4{dimer}:MD-2:LPS:LBP:CD14
--
e109
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m109
0
infinite
0
--
csml-variable:Double
m11
10
infinite
0
--
TRIF
--
e110
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m110
0
infinite
0
--
dsRNA:TLR3:TRIF
--
e111
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m111
0
infinite
0
--
TBK1:IKK-i
--
e112
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m112
0
infinite
0
--
dsRNA:TLR3:TRIF:TBK1:IKK-i
--
e113
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m113
0
infinite
0
--
dsRNA:TLR3:TRIF:TRAF6
--
e114
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m114
0
infinite
0
--
IRF-3
--
e115
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m115
0
infinite
0
--
IRF-3{active}
--
e116
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m116
0
infinite
0
--
IRF-3{active}
--
e117
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m117
0
infinite
0
--
dsRNA:TLR3:TRIF:TBK1{active}:IKK-i
--
e118
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m118
0
infinite
0
--
TRAF3
--
e119
cso30:c:Protein
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m119
0
infinite
0
--
TLR2:TLR6
--
e12
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m12
0
infinite
0
--
NAP1
--
e120
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m120
0
infinite
0
--
RIP1
--
e121
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m121
0
infinite
0
--
dsRNA:TLR3:TRIF:RIP1
--
e122
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m122
0
infinite
0
--
TRAF6{active}
--
e123
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m123
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
TRAM
--
e124
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m124
0
infinite
0
--
TLR4{dimer}:MD-2:LPS:LBP:CD14:TRAM
--
e125
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m125
0
infinite
0
--
TLR4{dimer}:MD-2:LPS:LBP:CD14:TRAM:TRIF
--
e126
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m126
0
infinite
0
--
TLR4{dimer}:MD-2:LPS:LBP:CD14:TRAM:TRIF:RIP1
--
e127
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m127
0
infinite
0
--
TAB2:TAK1{active}
--
e128
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m128
0
infinite
0
--
Mal{p}
--
e129
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m129
0
infinite
0
--
TLR2:TLR6:Diacylated lipoproteins
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m13
0
infinite
0
--
TRAF1
--
e130
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m130
0
infinite
0
--
TRIF:TRAF1
--
e131
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m131
0
infinite
0
--
SARM
--
e132
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m132
0
infinite
0
--
dsRNA:TLR3:TRIF:SARM
--
e133
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m133
0
infinite
0
--
TLR4{dimer}:MD-2:LPS:LBP:CD14:TRAM:TRIF:SARM
--
e134
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m134
0
infinite
0
--
TGF-Beta
--
e135
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m135
0
infinite
0
--
MyD88{ub}
--
e136
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m136
0
infinite
0
--
ST2
--
e137
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m137
0
infinite
0
--
IL-1:IL-1R
--
e138
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m138
0
infinite
0
--
Mal:TRAF6
--
e139
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m139
0
infinite
0
--
triacylated lipoproteins
--
e14
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
Btk
--
e140
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m140
0
infinite
0
--
Mal{p}
--
e141
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m141
0
infinite
0
--
SOCS1
--
e142
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m142
0
infinite
0
--
Mal{p}:SOCS1
--
e143
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m143
0
infinite
0
--
Mal{p}{ub}:SOCS1
--
e144
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m144
0
infinite
0
--
Caspase-1
--
e145
cso30:c:Protein
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m145
0
infinite
0
--
PKC-delta
--
e146
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m146
0
infinite
0
--
Mal:PKC-delta
--
e147
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m147
0
infinite
0
--
TLR2:TLR1:triacylated proteins
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
Lipoteichoic acid
--
e16
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
TLR2:Lipoteichoic acid
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
--
e18
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m18
0
infinite
0
--
--
e19
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
--
e20
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m20
0
infinite
0
--
TLR3
--
e21
cso30:c:Protein
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m21
0
infinite
0
--
dsRNA
--
e22
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
dsRNA:TLR3
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
TLR4
--
e24
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m24
0
infinite
0
--
LPS
--
e25
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
TLR5
--
e26
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m26
0
infinite
0
--
Flagellin
--
e27
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m27
0
infinite
0
--
TLR5:Flagellin
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m28
0
infinite
0
--
TLR7
--
e29
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
ssRNA
--
e30
cso30:c:Rna
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
TLR7:ssRNA
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
TLR8
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m32
0
infinite
0
--
TLR8:ssRNA
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m33
0
infinite
0
--
TLR9
--
e34
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m34
0
infinite
0
--
CpG DNA
--
e35
cso30:c:Dna
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
TLR9:CpG DNA
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
LBP
--
e37
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m37
0
infinite
0
--
LPS:LBP
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
CD14
--
e39
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
LPS:LBP:CD14
--
e40
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
MD-2
--
e41
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m41
0
infinite
0
--
TLR4:MD-2
--
e42
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
TLR4:MD-2:LPS:LBP:CD14
--
e43
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
CD36
--
e44
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m44
0
infinite
0
--
MyD88
--
e45
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
TLR4:MD-2:LPS:LBP:CD14:MyD88
--
e46
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
IRAK-4
--
e47
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m47
0
infinite
0
--
IRAK-1
--
e48
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m48
0
infinite
0
--
TLR4:MD-2:LPS:LBP:CD14:MyD88:IRAK-4:IRAK-1
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
diacylated lipoproteins
--
e5
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
TLR2:TLR1
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
TLR4:MD-2:LPS:LBP:CD14:MyD88:IRAK-4:IRAK-1{p}
--
e63
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
TLR4:MD-2:LPS:LBP:CD14:MyD88:IRAK-4:IRAK-1{p}:TRAF6
--
e64
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m64
0
infinite
0
--
TLR4:MD-2:LPS:LBP:CD14:MyD88:IRAK-4:IRAK-1{p}:TRAF6 oligomer
--
e65
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
Uev1a
--
e66
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m66
0
infinite
0
--
TLR4:MD-2:LPS:LBP:CD14:MyD88:IRAK-4:IRAK-1{p}:TRAF6 oligomer{ub}
--
e67
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m67
0
infinite
0
--
TLR4:MD-2:LPS:LBP:CD14:MyD88:IRAK-4:IRAK-1{p}:TRAF6 oligomer{ub}:TAB2:TAK1
--
e68
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m68
0
infinite
0
--
TAB2:TAK1
--
e69
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
TLR4:MD-2:LPS:LBP:CD14:MyD88:IRAK-4:IRAK-1{p}:TRAF6 oligomer{ub}:TAB2:TAK1{active}
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m70
0
infinite
0
--
csml-variable:Double
m71
10
infinite
0
--
NF-KappaB:IKappaB
--
e72
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m72
0
infinite
0
--
NF-KappaB:IKappaB{p}
--
e73
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m73
0
infinite
0
--
NF-KappaB:IKappaB{p}{ub}
--
e74
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m74
0
infinite
0
--
Proteasome degradants
--
e75
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
csml-variable:Double
m75
0
infinite
0
--
NF-KappaB{active}
--
e76
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m76
0
infinite
0
--
csml-variable:Double
m77
0
infinite
0
--
mRNA
--
e78
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m78
0
infinite
0
--
MKK6
--
e79
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m79
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
MKK6{active}
--
e80
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m80
0
infinite
0
--
JNK
--
e81
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m81
0
infinite
0
--
JNK{p}
--
e82
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m82
0
infinite
0
--
p38{p}
--
e83
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m83
0
infinite
0
--
csml-variable:Double
m84
0
infinite
0
--
AP-1
--
e85
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m85
0
infinite
0
--
AP-1{active}
--
e86
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m86
0
infinite
0
--
MyD88:TRAF6:IRAK-4:IRAk-1
--
e87
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m87
0
infinite
0
--
MyD88:TRAF6:IRAK-4:IRAK-1:TLR7:ssRNA
--
e88
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m88
0
infinite
0
--
IRF-7
--
e89
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m89
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
MyD88:TRAF6{ub}:IRAK-4:IRAK-1{p}:TLR7:ssRNA:IRF-7
--
e90
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m90
0
infinite
0
--
MyD88:TRAF6{ub}:IRAK-4:IRAK-1{p}:TLR7:ssRNA:IRF-7{p}
--
e91
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m91
0
infinite
0
--
IRF-7{p}
--
e92
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m92
0
infinite
0
--
MyD88:TRAF6:IRAK-4:IRAK-1{p}:TLR7:ssRNA
--
e93
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m93
0
infinite
0
--
MyD88:TRAF6{ub}:IRAK-4:IRAK-1{p}:TLR7:ssRNA
--
e94
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m94
0
infinite
0
--
IFN-alpha
--
e95
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m95
0
infinite
0
--
IFN inducible genes
--
e96
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m96
0
infinite
0
--
IRF5
--
e97
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m97
0
infinite
0
--
IRF5{active}
--
e98
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m98
0
infinite
0
--
IRF5{active}
--
e99
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m99
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
stoichiometry:c15 : 1
m3964*m11*0.1
nodelay
--
0
PMID: 17667936,12763684 There are also a number of ligands such as lipoteichoic acid and mycobacterial lipoarabinomannan that appear to be recognized by TLR2 independent of TLR1 or TLR6
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m34*m35*0.1
nodelay
--
0
PMID: 17667936 Both TLR7 and TLR8 recognize the single-stranded RNA (ssRNA) from viruses, while TLR9 is responsible for detecting bacterial and viral CpG DNA motifs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m37*m25*0.1
nodelay
--
0
PMID: 17667936,15010525,15895089 It seems that an LPS response requires the sequential interaction and transfer of LPS to LPS-binding protein, the glycosylphosphatidylinositol-anchored protein CD14 and MD-2, and the simultaneous engagement of LPS and TLR4 by MD-2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m38*m39*0.1
nodelay
--
0
PMID: 17667936,15010525,15895089 It seems that an LPS response requires the sequential interaction and transfer of LPS to LPS-binding protein, the glycosylphosphatidylinositol-anchored protein CD14 and MD-2, and the simultaneous engagement of LPS and TLR4 by MD-2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m41*m24*0.1
nodelay
--
0
PMID: 17667936,15010525,15895089 It seems that an LPS response requires the sequential interaction and transfer of LPS to LPS-binding protein, the glycosylphosphatidylinositol-anchored protein CD14 and MD-2, and the simultaneous engagement of LPS and TLR4 by MD-2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m42*m40*0.1
nodelay
--
0
PMID: 17667936,15010525,15895089 It seems that an LPS response requires the sequential interaction and transfer of LPS to LPS-binding protein, the glycosylphosphatidylinositol-anchored protein CD14 and MD-2, and the simultaneous engagement of LPS and TLR4 by MD-2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
stoichiometry:c46 : 1
m45*m108*0.1
nodelay
--
0
PMID: 17667936 MyD88 is recruited to the cytoplasmic portion of the TLR and interacts with IRAK4 and IRAK1 via homophilic DD interactions. PMID: 17667936 Mal recruits MyD88, which binds IRAK4 and -1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m47*m48*m46*0.1
nodelay
--
0
PMID: 17667936 MyD88 is recruited to the cytoplasmic portion of the TLR and interacts with IRAK4 and IRAK1 via homophilic DD interactions.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m49*0.1
nodelay
--
0
PMID: 17667936,11518704,9430229,12538665,12885415,11960013 17362201 Activated IRAK4 phosphorylates and activates IRAK1 which subsequently interacts with TNFR-associated factor-6 (TRAF6),causing the oligomerization and activation of TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m183*m63*0.1
nodelay
--
0
PMID: 17667936,11518704,9430229,12538665,12885415,11960013 17362201 Activated IRAK4 phosphorylates and activates IRAK1 which subsequently interacts with TNFR-associated factor-6 (TRAF6),causing the oligomerization and activation of TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m64*0.1
nodelay
--
0
PMID: 17667936,11518704,9430229,12538665,12885415,11960013 17362201 Activated IRAK4 phosphorylates and activates IRAK1 which subsequently interacts with TNFR-associated factor-6 (TRAF6),causing the oligomerization and activation of TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m3964*m3963*0.1
nodelay
--
0
PMID: 17667936,11095740,15795223,16720699 TLR2 is known to form heterodimers with TLR1 or TLR6 while TLR4 homodimerizes in a similar fashion to dToll
p20
p20
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m65*m6443*m66*0.1
nodelay
--
0
PMID: 17667936,16056267,11057907 TRAF6 is a ubiquitin E3 ligase and functions with the ubiquitin-conjugating enzyme Ubc13 and the Ubc-like protein Uev1a to catalyze the synthesis of Lys63-linked polyubiquitin chains on target proteins including TRAF6 itself.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m67*m69*0.1
nodelay
--
0
PMID: 17667936,16056267,11057907,10882101 Ubiquitinated TRAF6 then recruits TAB2 and activates the TAB2-associated TAK1 kinase
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m68*0.1
nodelay
--
0
PMID: 17667936,16056267,11057907,10882101 Ubiquitinated TRAF6 then recruits TAB2 and activates the TAB2-associated TAK1 kinase
p23
p23
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
stoichiometry:c69 : 1
m70*m207*0.1
nodelay
--
0
PMID: 17667936 Activated TAK1 then activates the IKK complex which phosphorylates IkappaB resulting in its ubiquitination and subsequent proteosome-mediated degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m71*m72*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m73*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m74*0.1
nodelay
--
0
PMID: 17667936 Activated TAK1 then activates the IKK complex which phosphorylates IkappaB resulting in its ubiquitination and subsequent proteosome-mediated degradation. PMID: 17667936,15371334,11460167 This leaves NF-kappaB free to translocate to the nucleus and initiate gene transcription
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m76*0.1
nodelay
--
0
PMID: 17667936,15371334,11460167 This leaves NF-kappaB free to translocate to the nucleus and initiate gene transcription
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
m77*0.1
nodelay
--
0
PMID: 17667936,15371334,11460167 This leaves NF-kappaB free to translocate to the nucleus and initiate gene transcription
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m70*m79*0.1
nodelay
--
0
PMID: : 17667936,11460167 TAK1 is also responsible for the activation of MKK6 which phosphorylates and activates the kinases JNK and P38 and thereby mediates AP-1 activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c43 : 1
stoichiometry:c9 : 1
m5*m12*m44*0.1
nodelay
--
0
PMID: 17667936,12077222 While the TLR2/TLR6 heterodimer detects diacylated lipoproteins from bacteria, the TLR2/TLR1 heterodimer senses triacylated lipoproteins. PMID: 17667936,15690042 CD14 has also been shown to be required for signalling induced by TLR2 ligands,and it has been found recently that the scavenger receptor CD36 is involved in recognition of diacylated lipopeptides by TLR2/6 heterodimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
stoichiometry:c87 : 1
m80*m81*0.1
nodelay
--
0
PMID: : 17667936,11460167 TAK1 is also responsible for the activation of MKK6 which phosphorylates and activates the kinases JNK and P38 and thereby mediates AP-1 activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c89 : 1
stoichiometry:c90 : 1
m80*m84*0.1
nodelay
--
0
PMID: : 17667936,11460167 TAK1 is also responsible for the activation of MKK6 which phosphorylates and activates the kinases JNK and P38 and thereby mediates AP-1 activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
stoichiometry:c93 : 1
m82*m85*0.1
nodelay
--
0
PMID: : 17667936,11460167 TAK1 is also responsible for the activation of MKK6 which phosphorylates and activates the kinases JNK and P38 and thereby mediates AP-1 activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c95 : 1
stoichiometry:c96 : 1
m83*m85*0.1
nodelay
--
0
PMID: : 17667936,11460167 TAK1 is also responsible for the activation of MKK6 which phosphorylates and activates the kinases JNK and P38 and thereby mediates AP-1 activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c98 : 1
stoichiometry:c99 : 1
m87*m31*0.1
nodelay
--
0
PMID: 17667936,15361868,15492225,15767370 Upon ligand binding to TLR 7, 8 or 9, IRF7 is recruited to a complex containing MyD88, TRAF6, IRAK4 and IRAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c108 : 1
stoichiometry:c109 : 1
m94*m89*0.1
nodelay
--
0
PMID: 17667936,15361868,15492225,15767370 Upon ligand binding to TLR 7, 8 or 9, IRF7 is recruited to a complex containing MyD88, TRAF6, IRAK4 and IRAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c111 : 1
m90*0.1
nodelay
--
0
PMID: 17667936 Phosphorylation of IRF7 by IRAK1 in this complex was found to be essential for its transcriptional activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c112 : 1
m91*0.1
nodelay
--
0
PMID: 17667936 This results in the activation of IRF7 which translocates to the nucleus to produce IFN-alpha and IFN-inducible genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c101 : 1
m88*0.1
nodelay
--
0
PMID: 17667936 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m93*0.1
nodelay
--
0
PMID: 17667936 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m14*m6*0.1
nodelay
--
0
PMID: 17667936,12077222 While the TLR2/TLR6 heterodimer detects diacylated lipoproteins from bacteria, the TLR2/TLR1 heterodimer senses triacylated lipoproteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
m92*0.1
nodelay
--
0
PMID: 17667936 This results in the activation of IRF7 which translocates to the nucleus to produce IFN-alpha and IFN-inducible genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c116 : 1
m92*0.1
nodelay
--
0
PMID: 17667936 This results in the activation of IRF7 which translocates to the nucleus to produce IFN-alpha and IFN-inducible genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c117 : 1
stoichiometry:c118 : 1
stoichiometry:c119 : 1
m67*m97*0.1
nodelay
--
0
PMID: 17667936 TRAF6 can also activate IRF5.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c121 : 1
m98*0.1
nodelay
--
0
PMID: 17667936,15665823 It was shown that IRF5 interacts with, and is activated by MyD88 and TRAF6 causing the nuclear translocation of IRF5 and the expression of inflammatory cytokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c123 : 1
m99*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m46*m101*0.1
nodelay
--
0
PMID: 17667936,17018642 Upon TLR activation, IRF1 is activated by MyD88, causing it to translocate to the nucleus where it induces a specific gene subset including IFN-beta, inducible NO synthase and IL-12p35
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c128 : 1
m102*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c129 : 1
stoichiometry:c130 : 1
m103*0.1
nodelay
--
0
PMID: 17667936,17018642 Upon TLR activation, IRF1 is activated by MyD88, causing it to translocate to the nucleus where it induces a specific gene subset including IFN-beta, inducible NO synthase and IL-12p35
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c132 : 1
m103*0.1
nodelay
--
0
PMID: 17667936,17018642 Upon TLR activation, IRF1 is activated by MyD88, causing it to translocate to the nucleus where it induces a specific gene subset including IFN-beta, inducible NO synthase and IL-12p35
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c133 : 1
stoichiometry:c134 : 1
m103*0.1
nodelay
--
0
PMID: 17667936,17018642 Upon TLR activation, IRF1 is activated by MyD88, causing it to translocate to the nucleus where it induces a specific gene subset including IFN-beta, inducible NO synthase and IL-12p35
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m3964*m16*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c136 : 1
stoichiometry:c138 : 1
stoichiometry:c137 : 1
m107*m109*0.1
nodelay
--
0
PMID: 17667936 It is initiated in the case of TLR4 by the TIR domain of Mal binding the TIR domain of TLR4, which has dimerized after ligand binding.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c135 : 1
stoichiometry:c169 : 1
m43*0.1
nodelay
--
0
PMID: 17667936 It is initiated in the case of TLR4 by the TIR domain of Mal binding the TIR domain of TLR4, which has dimerized after ligand binding.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c140 : 1
stoichiometry:c141 : 1
m23*m110*0.1
nodelay
--
0
PMID: 17667936 Figure 1 PMID: 17667936,14679297,14530355 TRIF mediates IRF3 activation via TRAF family member-associated NF-kappaB activator (TANK)-binding kinase 1 (TBK1), which associates with the N terminus of TRIF
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c143 : 1
stoichiometry:c144 : 1
m111*m112*0.1
nodelay
--
0
PMID: 17667936 Figure 1 PMID: 17667936,14679297,14530355 TRIF mediates IRF3 activation via TRAF family member-associated NF-kappaB activator (TANK)-binding kinase 1 (TBK1), which associates with the N terminus of TRIF
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c146 : 1
stoichiometry:c147 : 1
m111*m183*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c168 : 1
stoichiometry:c170 : 1
stoichiometry:c171 : 1
m109*m124*0.1
nodelay
--
0
PMID: 17667936,14517278 It functions as a bridging adaptor for the MyD88-independent signalling pathway, serving to recruit TRIF to TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c156 : 1
stoichiometry:c150 : 1
m115*m118*0.1
nodelay
--
0
PMID: 17667936 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c151 : 1
stoichiometry:c152 : 1
m116*0.1
nodelay
--
0
PMID: 17667936 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c154 : 1
m117*0.1
nodelay
--
0
PMID: 17667936 Figure 1
p59
p59
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c148 : 1
stoichiometry:c157 : 1
stoichiometry:c158 : 1
stoichiometry:c155 : 1
m113*m119*m120*0.1
nodelay
--
0
PMID: 17667936,16306937,16306936,15611223 Recently, both TRAF3 and NAK-associated protein 1 (NAP1) have been implicated in mediating the activation of TBK1 by TRIF by acting as a bridge between the two proteins
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m22*m21*0.1
nodelay
--
0
PMID: 17667936 TLR3 detects the double-stranded RNA (dsRNA) from viruses.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c160 : 1
stoichiometry:c161 : 1
m121*m111*0.1
nodelay
--
0
PMID: 17667936,15064760 TRIF also associates with receptor-interacting protein 1 (RIP1) via its C-terminal RIP homotypic interaction motif (RHIM), and in the absence of RIP1, TLR3-mediated NF-kappaB activation was abolished, suggesting that RIP1 mediates the TRIF-induced NF-kappaB activation
p61
p61
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c163 : 1
stoichiometry:c164 : 1
m122*m183*0.1
nodelay
--
0
PMID: 17667936 Alternatively RIP1 is activated by TRIF and this feeds into the MyD88 pathway by activating TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c165 : 1
stoichiometry:c166 : 1
stoichiometry:c167 : 1
m123*m97*0.1
nodelay
--
0
PMID: 17667936 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c172 : 1
stoichiometry:c173 : 1
stoichiometry:c174 : 1
m110*m125*0.1
nodelay
--
0
PMID: 17667936,14517278 It functions as a bridging adaptor for the MyD88-independent signalling pathway, serving to recruit TRIF to TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c175 : 1
stoichiometry:c176 : 1
stoichiometry:c177 : 1
m126*m121*0.1
nodelay
--
0
PMID: 17667936 Figure 1
p65
p65
cso30:i:ME_UnknownActivation
cso30:i:CC_EndosomeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c184 : 1
stoichiometry:c185 : 1
stoichiometry:c186 : 1
m128*m207*0.1
nodelay
--
0
PMID: 17667936 Figure 1
p61
p66
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c178 : 1
stoichiometry:c179 : 1
stoichiometry:c180 : 1
m122*m183*0.1
nodelay
--
0
PMID: 17667936 Alternatively RIP1 is activated by TRIF and this feeds into the MyD88 pathway by activating TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c181 : 1
stoichiometry:c182 : 1
stoichiometry:c183 : 1
m123*m69*0.1
nodelay
--
0
PMID: 17667936 Figure 1
p65
p68
cso30:i:ME_UnknownActivation
cso30:i:CC_EndosomeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c187 : 1
stoichiometry:c188 : 1
stoichiometry:c189 : 1
m128*m79*0.1
nodelay
--
0
PMID: 17667936 Figure 1
p65
p69
cso30:i:ME_UnknownActivation
cso30:i:CC_EndosomeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c190 : 1
stoichiometry:c191 : 1
stoichiometry:c192 : 1
m127*m183*0.1
nodelay
--
0
PMID: 17667936 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m27*m26*0.1
nodelay
--
0
PMID: 17667936 TLR5 senses flagellin, a highly conserved component of bacterial flagella.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c193 : 1
stoichiometry:c195 : 1
stoichiometry:c194 : 1
m107*m25*0.1
nodelay
--
0
PMID: 17667936 It was found that TRAM was phosphorylated on serine-16 by PKCalt epsilon upon LPS stimulation PMID: 17667936 Figure 2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c196 : 1
stoichiometry:c197 : 1
stoichiometry:c198 : 1
m130*m110*0.1
nodelay
--
0
PMID: 17667936 The TIR domain of TRIF was involved in the interaction with the TRAF-C domain of TRAF1, and inhibition most likely occurs through sequestration of the TIR domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c199 : 1
stoichiometry:c200 : 1
stoichiometry:c201 : 1
m111*m132*0.1
nodelay
--
0
PMID: 17667936 SARM associates with TRIF and blocks TRIF-induced NF-kappaB activation.
p73
p73
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c202 : 1
stoichiometry:c203 : 1
stoichiometry:c205 : 1
stoichiometry:c204 : 1
m111*m72*0.1
nodelay
--
0
PMID: 17667936 SARM associates with TRIF and blocks TRIF-induced NF-kappaB activation.
p73
p74
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c206 : 1
stoichiometry:c207 : 1
stoichiometry:c212 : 1
stoichiometry:c226 : 1
stoichiometry:c208 : 1
m126*m72*0.1
nodelay
--
0
PMID: 17667936 SARM associates with TRIF and blocks TRIF-induced NF-kappaB activation. PMID: 17667936 It was found that the membrane bound form of ST2, which contains a TIR domain, specifically inhibited NF-kappaB activation downstream of IL-1R, TLR2, TLR4 and TLR9 but not TLR3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c209 : 1
stoichiometry:c210 : 1
stoichiometry:c211 : 1
m126*m132*0.1
nodelay
--
0
PMID: 17667936 SARM associates with TRIF and blocks TRIF-induced NF-kappaB activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c213 : 1
stoichiometry:c214 : 1
stoichiometry:c215 : 1
m135*m45*0.1
nodelay
--
0
PMID: 17667936 Transforming growth factor-beta (TGF-beta) partly exerts its anti-inflammatory effects by causing direct ubiquitination of MyD88, thereby augmenting its degradation by the proteasome.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c216 : 1
stoichiometry:c217 : 1
m136*0.1
nodelay
--
0
PMID: 17667936 Transforming growth factor-beta (TGF-beta) partly exerts its anti-inflammatory effects by causing direct ubiquitination of MyD88, thereby augmenting its degradation by the proteasome.
p78
p78
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c218 : 1
stoichiometry:c219 : 1
stoichiometry:c221 : 1
stoichiometry:c220 : 1
m138*m72*0.1
nodelay
--
0
PMID: 17667936 It was found that the membrane bound form of ST2, which contains a TIR domain, specifically inhibited NF-kappaB activation downstream of IL-1R, TLR2, TLR4 and TLR9 but not TLR3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c222 : 1
stoichiometry:c223 : 1
stoichiometry:c225 : 1
stoichiometry:c224 : 1
m15*m72*0.1
nodelay
--
0
PMID: 17667936 It was found that the membrane bound form of ST2, which contains a TIR domain, specifically inhibited NF-kappaB activation downstream of IL-1R, TLR2, TLR4 and TLR9 but not TLR3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m30*m29*0.1
nodelay
--
0
PMID: 17667936 Both TLR7 and TLR8 recognize the single-stranded RNA (ssRNA) from viruses, while TLR9 is responsible for detecting bacterial and viral CpG DNA motifs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c227 : 1
stoichiometry:c228 : 1
stoichiometry:c230 : 1
stoichiometry:c229 : 1
m36*m72*0.1
nodelay
--
0
PMID: 17667936 It was found that the membrane bound form of ST2, which contains a TIR domain, specifically inhibited NF-kappaB activation downstream of IL-1R, TLR2, TLR4 and TLR9 but not TLR3.
p81
p81
cso30:i:ME_Binding
cso30:i:CC_EndosomeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c231 : 1
stoichiometry:c232 : 1
stoichiometry:c233 : 1
m107*m183*0.1
nodelay
--
0
PMID: 17667936 Indeed, Mal could associate with TRAF6 in a co-immunoprecipitation assay.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c234 : 1
stoichiometry:c235 : 1
stoichiometry:c236 : 1
m140*m107*0.1
nodelay
--
0
PMID: 17667936 It was also shown that Mal is phosphorylated by Bruton's tyrosine kinase (Btk) on tyrosine residues at positions 86 and 187, and this event is necessary for efficient TLR4 signalling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c237 : 1
stoichiometry:c238 : 1
stoichiometry:c239 : 1
m141*m142*0.1
nodelay
--
0
PMID: 17667936 A prerequisite for Mal degradation is tyrosine phosphorylation of Mal by Btk as this may allow SOCS1 to associate with Mal through its SH2 domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c240 : 1
stoichiometry:c241 : 1
m143*0.1
nodelay
--
0
PMID: 17667936 Here it was shown that SOCS1 mediates polyubiquitination of Mal on two N-terminal lysine residues, thereby mediating Mal degradation via the 26S proteasome.
p85
p85
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c242 : 1
stoichiometry:c243 : 1
stoichiometry:c244 : 1
m144*0.1
nodelay
--
0
PMID: 17667936 Here it was shown that SOCS1 mediates polyubiquitination of Mal on two N-terminal lysine residues, thereby mediating Mal degradation via the 26S proteasome.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c245 : 1
stoichiometry:c246 : 1
stoichiometry:c247 : 1
m145*m107*0.1
nodelay
--
0
PMID: 17667936 It was also recently found that Mal is cleaved by caspase-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c248 : 1
stoichiometry:c249 : 1
stoichiometry:c250 : 1
m146*m107*0.1
nodelay
--
0
PMID: 17667936,17161867 In addition, Mal was shown to interact via its TIR domain with protein kinase C-delta (PKCdelta)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m30*m32*0.1
nodelay
--
0
PMID: 17667936 Both TLR7 and TLR8 recognize the single-stranded RNA (ssRNA) from viruses, while TLR9 is responsible for detecting bacterial and viral CpG DNA motifs.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--